New code means acceptance of focused ultrasound technology as mainstream treatment, leading to standardized reimbursement for US physicians

新代码意味着接受聚焦超声技术作为主流治疗，导致美国医生的标准化报销

HAIFA, Israel and MIAMI, Nov. 2, 2023 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that the editorial panel of the American Medical Association (AMA) approved their application to establish a new Category (Cat) I Current Procedural Terminology (CPT®) code to facilitate reimbursement for MR-guided focused ultrasound (MRgFUS) ablation of neurological targets.

2023年11月2日，以色列海法和迈阿密/PRNewswire/-Insightec，一家致力于利用声能改变患者护理的全球医疗保健公司，今天宣布，美国医学协会（AMA）的编辑小组批准了他们的申请，以建立一个新的类别（Cat）I现行程序术语（CPT®）代码，以便于报销MR引导聚焦超声（MRgFUS）神经系统消融目标。

The Cat I CPT® code will be included in the next CPT® codebook and expected to be effective January 1, 2025..

Cat I CPT®代码将包含在下一个CPT®代码簿中，预计将于2025年1月1日生效。。

'Achieving a Cat I CPT® code is a tremendous milestone for not only Insightec, but for patients and physicians across the United States,' explains Maurice R. Ferré, MD, CEO and chairman of the board of Insightec. 'We've long known that focused ultrasound has a significant and valuable role in treating patients with neurological disorders.

Insightec首席执行官兼董事会主席莫里斯·R·费雷（Maurice R.Ferré）解释说：“实现Cat I CPT®代码不仅是Insightec的一个巨大里程碑，也是美国各地患者和医生的一个里程碑。”我们早就知道聚焦超声在治疗神经系统疾病患者方面具有重要和有价值的作用。

The approval of this code is further validation and indication of the broader adoption of focused ultrasound, and assurance that those who provide this critical service will receive consistent reimbursement.'.

该代码的批准进一步验证并表明聚焦超声的广泛采用，并确保提供此关键服务的人员将获得一致的报销。

'This approval can also lead to expanded access to focused ultrasound for US patients,' says Dee Kolanek, vice president of market access and reimbursement for Insightec. 'Thanks to the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) who supported the application, this code now gives physicians a definitive reimbursement and, we believe, will have a positive impact on both sales and utilization going forward.'.

“这项批准还可以扩大美国患者对聚焦超声的使用范围，”Insightec市场准入和报销副总裁Dee Kolanek说感谢美国神经外科医师协会（AANS）和神经外科医师大会（CNS）支持该申请，该代码现在为医生提供了明确的报销，我们相信，这将对未来的销售和利用产生积极影响。''。

Focused ultrasound, which was pioneered by Insightec, is FDA approved to treat essential tremor and Parkinsonian tremor. The procedure is performed in a single, outpatient procedure with many patients showing immediate improvement of tremor in the treated hand with minimal or no complications. There are currently over 50 treatment centers across the United States and more than 125 treatment centers around the world using Insightec's Exablate® Neuro platform..

由Insightec开创的聚焦超声是FDA批准用于治疗原发性震颤和帕金森病震颤。该程序在单个门诊程序中进行，许多患者在治疗的手中显示出震颤的立即改善，并发症很少或没有。目前，美国有超过50个治疗中心，世界各地有超过125个治疗中心使用Insightec的Exablate®Neuro平台。。

About Insightec

关于Insightec

Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson's disease.

Insightec是一家全球医疗保健公司，通过实现声能的治疗能力，创造下一代患者护理。该公司的Exablate Neuro平台在MRI的安全引导下聚焦声波，为患有药物难治性原发性震颤和帕金森病的患者提供震颤治疗。

Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo..

与领先的学术和医疗机构合作，正在进行神经科学领域未来应用的研究。Insightec总部设在以色列海法和迈阿密，在达拉斯，上海和东京设有办事处。。

Follow us on Facebook, LinkedIn and Twitter or visit www.insightec.com for more information.

在Facebook，LinkedIn和Twitter上关注我们，或访问www.insightec.com获取更多信息。

Forward-looking Statements:

前瞻性声明：

This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: 'may,' 'can,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'intend,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'promise,' 'continue,' 'ongoing,' or the negative of these terms.

本文件包含有关计划，期望和未来事件等前瞻性声明。在某些情况下，前瞻性陈述可以用以下词语来表示：“可能”，“可以”，“将会”，“可以”，“将会”，“应该”，“期望”，“打算”，“计划”，“预期”，“相信”，“估计”，“预测”，“项目”，“潜力”，“承诺”，“继续”，“正在进行”或这些条款的否定。

Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement.

前瞻性陈述涉及已知和未知的风险，不确定性和其他可能导致实际结果与陈述所表达或暗示的实质性差异的重要因素。任何前瞻性声明均基于截至声明之日Insightec可获得的信息。

All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec's expectations..

所有书面或口头前瞻性声明都可以归因于这种谨慎。Insightec不承担任何更新或修改任何前瞻性声明的义务，以反映情况或Insightec期望的任何变化。。

'Exablate,' and 'Exablate Neuro,' as well as the 'INSIGHTEC' logo, whether standing alone or in connection with the word 'Insightec', are protected trademarks of Insightec.

“Exablate”和“Exablate Neuro”以及“INSIGHTEC”徽标，无论是单独站立还是与“INSIGHTEC”一词相关，都是INSIGHTEC的受保护商标。

Insightec Media Contact:G&S Business Communications for InsightecMarjani Williams[email protected](312) 648-6700, ext.2108

Insightec媒体联系人：InsightecMarjani Williams的G＆S商业通讯[电子邮件保护]（312）648-6700，分机2108

Photo - https://mma.prnewswire.com/media/1699588/4172473/Insightec_Logo.jpg

Photo - https://mma.prnewswire.com/media/1699588/4172473/Insightec_Logo.jpg

SOURCE INSIGHTEC

来源INSIGHTEC